AI加速进击多模态、强推理，"引爆"了算力和存储，但供给却严重短缺。 尤其在国内，AI基建狂潮持续，高端GPU芯片的缺口已高达百亿元规模。 另据方正证券测算，若AI手机规模化上市，将激发大量12nm以下的晶圆需求，而国内现有产能还不到一半。 存储的缺口更大。在发达国家，存算比投资约是1:1，但在国内，存算比投资仅为0.4:1，明显失衡。 因此，我国存储芯片长期存在15%—20%的贸易逆差，且对外依存度较高，只能被动接受国外科技巨头涨价。 中国要抢占AI应用"制高点"，必须抓紧"补课"，科技必须自立自强。也就是说，GPU和存储的国产替代，以及存储扩产、先进制程扩产，势在必行。 其间，作为上游的基础设施，国产半导体设备也有望维持高景气。 东吴证券预测，2026年AI驱动，国产半导体设备将开启确定性强的扩产周期，全行业订单增速或将超过30%。 中国AI如火如荼，但深处，却潜藏着重大危机。 算力，是AI时代的"水电煤"，决定着创新的上限。GPU负责提供算力，但截至2024年末，海外巨头在国内GPU市场的占有率超过96%。 存储，主要是DRAM内存芯片和NAND闪存芯片，被誉为AI时代的"数据粮仓"。海外公司全球市占率 ...

半玉 蛋 wabao WP Fund 【 】 【 】 【 】 【 】 】 【 】 】 2026年01月 ll 3A系列ETF当日场内行情 ■ 中证A100ETF基金 A50ETF华宝 A500ETF华宝 159596 562000 563500 +0.0% -0.15% -0.45% 数据来源:沪深交易所等,行情数据截至 TF华宝于2024.3.18上市,中证A100ETF基金于2022.8.1上 市,A500ETF华宝于2024.12.2上市 当日大市行情 na +0.05% +0.31% +0.06% 创业板指 上证指数 深证成指 两市成交额2.85万亿元 较上一日+476亿元 全市场个股涨跌数 3190只 2173 层 107只 at 上涨 == 持平 " 下跌 资金净流入TOP3行业(申万一级) +0.05% +0.06% +0.31% 创业板指 上证指数 深证成指 两市成交额2.85万亿元 较上一日+476亿元 全市场个股涨跌数 3190只 2173 및 107只 =1 上涨 === 持平 "| 下跌 资金净流入TOP3行业(申万一级) 银行 煤炭 通信 +9.03亿元 +28.14亿元 +12.4 ...

渔业股午后放量上攻，中水渔业(000798)下午开盘后快速涨停。芯片概念股批量涨停。 昨日，商务部发布2026年第1号公告 《关于加强两用物项对日本出口管制的公告》，宣布根据《出口管制法》等法律法规有关规定，禁止所有两用物项对 日本军事用户、军事用途，以及一切有助于提升日本军事实力的其他最终用户用途出口，任何国家和地区的组织和个人违反上述规定将原产于中华人民共 和国的相关两用物项转移或提供给日本的组织和个人，将依法追究法律责任。 去年底，中国外交部发言人毛宁曾表示，由于日本首相高市早苗倒行逆施，在台湾等重大问题上的错误言论引起中国民众的强烈公愤。当前形势下，即使 日本水产品向中国出口，也不会有市场。二级市场上，A股水产概念股时常出现脉冲式走强行情，反映出市场对国内产能填补空缺的强烈预期。 1月7日，A股整体小幅震荡，上证指数盘中虽有波动，但仍顽强收红，日K线上罕见连续14根阳线，深证成指、创业板指等也微幅上涨，大盘蓝筹股略有 调整，上证50、沪深300微幅飘绿。下跌个股远多于上涨个股，市场成交温和放大至2.88万亿元。 盘面上，芯片、渔业、酒店餐饮、次新股等板块表现活跃，油气开采、专业连锁、航天装备、人脑工程 ...

| | | 目 录 | | 每日报告精选（2026-01-06 09:00——2026-01-07 15:00） 2 | | | --- | --- | --- | |  | 策略观察：《元旦文旅景气增长，科技周期延续涨价》2026-01-07 | 2 | |  | 海外策略研究：《岁末年初躁动下亚洲市场领涨》2026-01-06 | 3 | |  | 策略专题报告：《新兴产业空间广阔，看多中国产业龙头》2026-01-06 | 3 | |  | 行业跟踪报告：海外科技《CES：NVDA、INTEL 算力升级，物理 AI 成推进焦点》2026-01-06 | 4 | |  | 公司公告点评：众鑫股份（603091）《启动美国工厂布局，夯实成长动能》2026-01-07 | 5 | |  | 海外报告：十月稻田（9676）《强效率，拓品类、扩新渠》2026-01-07 | 6 | |  | 海外报告：明略科技-W（2718）《核心业务稳健，强化数据智能龙头地位》2026-01-06 | 7 | |  | 公司公告点评：中国巨石（600176）《激励如期落地，彰显发展信心》2026-01-06 | ...

1.光刻胶 一、行情回顾 沪指全天窄幅震荡，盘中逼近4100点关口，创业板指冲高回落。光刻机、光刻胶概念股走强，南大光电、国风新材等多股涨停。煤炭板块集体拉升，大有能 源、安泰集团等涨停。商业航天概念继续活跃，雷科防务6连板，金风科技等涨停。半导体设备股延续强势，中微公司、北方华创大涨续创历史新高。下跌 方面，脑机接口概念下挫，诚益通、爱朋医疗等跌超10%。个股跌多涨少，沪深京三市近3200股飘绿，今日成交2.88万亿。 二、当日热点 光刻胶板块今日大涨，国风新材、彤程新材、华融化学、常青科技、高盟新材等涨停。 催化上，据上证报报道，近日，威耀实业发生股东信息变更，持股100%的上海微电子退出，芯上微装成为威耀实业的新增全资股东，认缴出资额同样为 2.285亿元。 有业内人士表示，芯上微装是从上海微电子分拆出的公司，核心团队来自上海微电子。此番芯上微装收购威耀实业，或许意味着其重新回到"上海微电子旗 下相关资产上市平台"的定位。 | 股票名称 | | 最新价 = | 涨跌幅 = | 涨停时间 = | 换手率 = | 流通市值 = | | | --- | --- | --- | --- | --- | --- ...

投资者关系 活动类别 ☑ 特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位名称 及人员姓名 平安基金-刘文平 时间 2026 年 1 月 7 日 地点 腾讯会议 上市公司接待 人员姓名 董事会秘书 郜雨 投资者关系活动 主要内容介绍 投资者问答主要内容： 1.如何展望 2026 年经营预期？ 答： 公司 2026 年将聚焦国内外双市场发力：国内市场持续赋 能义齿加工厂与口腔医疗服务机构，通过数字种植、美学修复、 全口活动义齿等新方案，同步提升下游客户竞争力与患者诊疗 体验；海外市场深耕细作，精准对接客户需求，强化产品组合 与解决方案交付能力，依托现有客户关系及品牌优势挖掘价值 客户。凭借团队的不懈努力，公司对实现业绩稳步增长充满信 心。 2.公司临床端客户和技工端客户的区别是什么？ 答： （1）定位与角色不同：临床端客户是口腔医院、诊所等 直接服务患者的诊疗机构，是诊疗方案的执行者；技工端客户 是义齿加工厂等专业生产机构，专注修复体（义齿、牙冠等） 制作，是临床诊疗的后端支撑。 （2）核心需求与合作重点不同：临床端更关注能 ...

Core Viewpoint - The battery cell temperature sensor market is projected to reach $3.424 billion by 2032, with a compound annual growth rate (CAGR) of 8.99% in the coming years [1][5]. Industry Overview - Battery cell temperature sensors are critical components in battery management systems, used for real-time monitoring of individual cell temperatures to prevent thermal runaway, optimize charge and discharge efficiency, and extend battery lifespan [1]. - The supply chain includes upstream components like semiconductor materials and packaging materials, midstream manufacturing and calibration, and downstream applications in electric vehicles, consumer electronics, and energy storage systems [1]. Market Dynamics Key Drivers - Stricter safety regulations for power batteries are driving the need for real-time, high-precision monitoring of cell temperatures, as mandated by various international standards [5]. - The proliferation of high-energy-density batteries, such as nickel-rich and silicon-carbon anodes, increases the demand for high-end sensors due to their heightened thermal sensitivity [6]. - The evolution of battery management systems towards a "cloud + edge" architecture necessitates advanced temperature data inputs for AI thermal runaway warning models, pushing sensors from single-point to multi-point distributed monitoring [6]. Major Obstacles - Cost pressures and intense price competition are compressing the unit price of temperature sensors, making it difficult for small and medium enterprises to invest in high-precision technology development [7]. - Long-term reliability testing requirements, such as AEC-Q200 certification, pose challenges for domestic manufacturers in terms of material stability and packaging processes [7]. - Low standardization across different battery structures and installation methods complicates the design and integration of temperature sensors [7]. Industry Opportunities - The emergence of solid-state batteries, which operate over a wider temperature range, is creating demand for new temperature sensing technologies, such as film-type and wireless sensors [8]. - The trend towards domestic supply chain localization by leading battery manufacturers is opening opportunities for local sensor companies with automotive-grade certification [8]. - The integration of multiple sensing parameters (temperature, voltage, pressure) into single sensors is becoming a trend, enhancing space utilization and system efficiency [8].

7日，A股早盘强势上扬，沪指盘中逼近4100点，续创逾10年新高；午后一度回落翻绿；港股走势疲弱，恒生指数跌近1%，恒生 科技指数跌1.49%。 半导体产业链股强势 光刻机、存储芯片、先进封装等半导体产业链股盘中集体爆发，截至收盘，南大光电、芯源微、恒坤新材等20%涨停，安集科技涨近 19%，普冉股份涨近12%，北方华创涨逾6%、兆易创新涨近5%。值得注意的是，芯源微、普冉股份、北方华创、兆易创新等盘中均创历史 新高。 | 代码 名称 | � | 涨幅% | 现价 | 涨跌 | 买价 | 卖价 总量 | | --- | --- | --- | --- | --- | --- | --- | | 300346 南大河里 | | R 20.00 | 55.19 | 9.20 | 55.19 | - 196.5万 | | 688037 2 原微 | | K 20.00 | 190.79 | 31.80 | 190.79 | l 107037 | | 688727 恒坤新材 | | K 19.99 | 62.06 | 10.34 | 62.06 | - 209984 | | 688019 安集科技 | | K 18. ...

Core Viewpoint - The article emphasizes the importance of selecting the right sectors in the A-share market, particularly focusing on emerging industries supported by government policies, such as integrated circuits, new energy, and biomedicine, which are expected to yield significant returns in the coming year [1]. Group 1: Selection Logic - The ten selected stocks are based on three hard standards: policy support, performance certainty, and reasonable valuation [3]. - Policy support is derived from the Ministry of Industry and Information Technology's focus on emerging pillar industries, which will benefit from research subsidies and industrial support [3]. - Performance is guaranteed with expected revenue/net profit growth of at least 20% and a return on equity (ROE) of at least 15% by 2025, with data sourced from company annual reports [3]. - Valuation is considered reasonable if the price-to-earnings (PE) and price-to-book (PB) ratios are below industry averages or at historical lows, providing a safety margin [3]. Group 2: Potential Stocks Analysis - The ten companies span key sectors such as semiconductors, new energy, and biomedicine, each with solid growth logic supported by authoritative data [5]. - Notable companies include: - Northern Huachuang (002371): A leader in semiconductor equipment with a leading domestic market share and a PEG of 1.2 [5]. - China Great Wall (000066): A core player in the Xinchuang hardware sector with a historical low PE of approximately 28 times and strong asset integration expectations [5]. - Desheng Technology (002908): A small-cap stock benefiting from social security services and data rights, with high elasticity expected as policies accelerate in 2026 [5]. Group 3: Core Sector Opportunities - Three key sectors are highlighted for their concentrated policy benefits and strong growth certainty: - Semiconductors and domestic substitution: The Ministry of Industry and Information Technology is promoting industrial foundation reconstruction, benefiting companies like SMIC and Northern Huachuang [6]. - New energy (photovoltaics and energy storage): The national energy work conference aims for an additional 200 million kilowatts of wind and solar installations by 2026, with companies like Longi Green Energy and CATL positioned to benefit [6]. - Biomedicine and innovative drugs: As an emerging pillar industry, stable policies and accelerated overseas expansion are expected to benefit companies like Heng Rui Medicine and Huahai Pharmaceutical [6]. Group 4: Practical Guide for Investors - Investors are advised to utilize three practical methods to seize opportunities without falling into pitfalls: - Verify authoritative information by checking company annual reports on the Shanghai and Shenzhen Stock Exchanges to confirm performance and order status [8]. - Diversify investments by selecting 1-2 stocks from each of the semiconductor, new energy, and biomedicine sectors to mitigate risks [8].

创新药已经突围成功。 "十五五"规划开局之年，医药行业在2026年将呈现创新药爆发、CXO回暖、中药转型、药店收缩、医院 洗牌、并购潮涌的总体格局，行业分化加剧，强者恒强。 创新药：20款重磅新药有望获批 在2025年，共有76个创新药物成功获批上市，数量较上年增长58%。与此同时，创新药对外授权交易活 跃，交易数量突破150起，累计交易总额更是高达1300亿美元以上，彰显了我国创新药产业的强劲发展 势头。 西部证券指出，2026年创新药行情将从"BD为王"转向"数据为王"，全球多中心临床试验数据读出将成 为核心催化。 随着临床数据和上市审批的加速，2026年，中国创新药出海会迎来爆发期。业内预测，2026年将有约20 款重磅新药有望在中国获批上市，涵盖肿瘤、感染性疾病、罕见病、自身免疫性疾病、神经系统疾病等 多个治疗领域。比如，BL-B01D1是百利天恒自主研发的全球首创EGFR×HER3双抗ADC，用于治疗复 发性或转移性食管鳞癌。作为全球首个被纳入优先审评的EGFR×HER3双抗ADC，它填补了PD-1/PD-L1 联合化疗失败患者的治疗空白。此外，BL-B01D1的鼻咽癌适应症也已获优先审评，预计20 ...